Sign In
NewsRadar

KREATECH Diagnostics (acquired by Leica)

Kreatech Diagnostics is a molecular diagnostics company focused on the development and commercialization of DNA probes and nucleic acid labeling technologies that are utilized for diagnostics and research applications in the life sciences and healthcare industry, specifically cytogenetics, molecular pathology, and microarrays.

• Show past press releases
• Edit this company

Contact Information
Address:
 
 
Phone:
Fax:
Web:
Contact:
 
 
Vlierweg 20
Amsterdam 1032 LG
Netherlands
+31 20 691 91 81
+ 31 20 630 42 47
http://www.kreatech.com
Harald Berninger
+31 20 691 91 81

Company Facts
Founded:Jan 1990
Founders:Hendrik-Jan Houthoff, Herman Volkers
CEO:Kees Moonen
CTO or technical lead:Herman Volkers
CFO or finance director:
Head of Sales:Harald Berninger
Head of Marketing:Harald Berninger

Stage:Growth
Category:Biotechnology & Healthcare
Sector:Diagnostics
Employees:50
Profitability:
Funding raised:Yes
Funding sought:
Seeking Partnerships:No

Non-executive Board Members

Key Customers

Key Business Partners

  • Qiagen
  • PerkinElmer
  • Sigma
  • QBiogene
  • Roche

    Key Competitors

    Capital Raised
    DateSizeInvestors
    To view this information you must be signed in and subscribed to the online dataservice, sign in here.

    To read more about the Online data service click here

    Public Offerings
    DateTypeExchange
    No public offerings


  • Data


    19,484
    Tech investments
    From our Online Data Service
    12,534
    VC-backed companies
    From our Radar


    Recent Deals


    DATEAMOUNTSECTOR
    Feb 24N/AConsumer applications
    Feb 24€9.0MBiopharmaceuticals
    Feb 24€0.4MInternet services
    Feb 23€4.2MBusiness applications
    Feb 23N/ADiagnostics
    Feb 22€4.4MSecurity
    Feb 20€2.0MWireless applications

    For information on Europe's most extensive database on technology funding click here!

    Events



    Press Releases


    Mar 2
    Iris Capital
    adotmob raises € 1m from iris capital and kerala ventures

    Mar 2
    High-Tech Gründerfonds Management
    htgf portfolio company outfittery raises $20 million led by new inv...

    Mar 2
    Themis Bioscience
    themis bioscience’s chikungunya vaccine study results published in ...

    Mar 2
    Alizé Pharma
    alizé pharma launches phase ii clinical trial of azp-531 in prader-...

    Mar 2
    Implandata Ophthalmic Products (IOP)
    implandata: first keratoprosthesis patient in europe receives perma...





    About usContact usLegal Information
    Copyright © 1999-2015
    Emerging Technology Research Europe Inc. All rights reserved.